Abbott Laboratories (ABT) FCF Payout Ratio (2009 - 2026)

Abbott Laboratories has disclosed FCF Payout Ratio across 18 years of filings, most recently posting 0.55 for Q2 2026.

• In Q2 2026, FCF Payout Ratio fell 16.9% year-over-year to 0.55; the TTM figure through Jun 2026 stood at 0.54 (down 7.13% YoY), while the FY2025 annual figure was 0.56, down 7.85% from the prior year.
• FCF Payout Ratio came in at 0.55 for Q2 2026 at Abbott Laboratories, down from 1.2 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 1.53 in Q1 2024 to a low of 0.36 in Q3 2022.
• Average FCF Payout Ratio over 5 years is 0.7, with a median of 0.52 recorded in 2026.
• Year-over-year, FCF Payout Ratio soared 213.66% in 2023 and plunged 47.34% in 2024.
• Over 5 years, FCF Payout Ratio stood at 0.48 in 2022, then decreased by 18.9% to 0.39 in 2023, then climbed by 14.66% to 0.45 in 2024, then dropped by 12.05% to 0.39 in 2025, then soared by 41.11% to 0.55 in 2026.
• Per Business Quant data, the three most recent FCF Payout Ratio figures were 0.55 in Q2 2026, 1.2 in Q1 2026, and 0.39 in Q4 2025.